Related Experiment Video

Updated: Aug 20, 2026

A Pre-Clinical Model of Synovitis Using Ex vivo Human Synovial Tissue with Preserved Function and Architecture
08:32

A Pre-Clinical Model of Synovitis Using Ex vivo Human Synovial Tissue with Preserved Function and Architecture

Published on: March 20, 2026

Matrix catabolism in arthritis: priming the guns with oncostatin M

Carl D Richards

    The Journal of Rheumatology
    |December 1, 2004
    PubMed
    Abstract

    No abstract available in PubMed .

    Related Experiment Videos

    Last Updated: Aug 20, 2026

    A Pre-Clinical Model of Synovitis Using Ex vivo Human Synovial Tissue with Preserved Function and Architecture
    08:32

    A Pre-Clinical Model of Synovitis Using Ex vivo Human Synovial Tissue with Preserved Function and Architecture

    Published on: March 20, 2026

    Related Concept Videos

    The JAK-STAT Signaling Pathway01:20

    The JAK-STAT Signaling Pathway

    Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...

    Articles linked to this work by shared authors, journal, and citation graph.

    Inactivation of interleukin-15 reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice.

    Frontiers in physiology·2026

    Influenza A/PR8 virus infection in mice suppresses basal and Oncostatin M-induced IL-33 expression in vivo and in vitro.

    Scientific reports·2026

    Biophysical and Biochemical Regulation of Cell Dynamics in Magnetically Assembled Cellular Structures.

    ACS omega·2023

    Myeloid-specific deletion of activating transcription factor 6 alpha increases CD11b+ macrophage subpopulations and aggravates lung fibrosis.

    Immunology and cell biology·2023

    Type I Interferon Signaling is Required for Oncostatin-M Driven Inflammatory Responses in Mouse Lung.

    Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research·2022

    Type I interferon regulates proteolysis by macrophages to prevent immunopathology following viral infection.

    PLoS pathogens·2022

    Rethinking Anti-CD20 Therapies: From Fixed to Precision Dosing.

    The Journal of rheumatology·2026

    Longitudinal comparison of treat-to-target states and clinical outcomes in patients with late-onset versus early-onset systemic lupus erythematosus.

    The Journal of rheumatology·2026

    Remission rates of patients with axial spondyloarthritis in a tertiary care center.

    The Journal of rheumatology·2026

    Uncovering heterogeneous health burden in axial spondyloarthritis through latent class analysis of the ASAS health index.

    The Journal of rheumatology·2026

    Mendelian randomisation for rheumatology: beyond hype-what it's good for, what it can't do, and how to read it critically.

    The Journal of rheumatology·2026

    Juvenile Arthritis Quality of Life Questionnaire Responder Metrics in Juvenile Idiopathic Arthritis: Clarifying Health-Related Quality of Life Changes Across Treatment Eras.

    The Journal of rheumatology·2026

    Regulatory roles of pyroptosis-associated lncRnas in breast cancer progression and immune microenvironment.

    Cell cycle (Georgetown, Tex.)·2026

    Insights Into the Mechanisms of Biological Aging That Guide Translational and Clinical Research.

    Aging medicine (Milton (N.S.W))·2026

    Depletion of Soluble PD-L1 with Engineered Nanoparticles Promotes Antitumor Immunity and Tumor Control.

    International journal of nanomedicine·2026

    Biomaterial-based Drug delivery strategies for head and neck cancer: Local delivery, combination therapy, and translational challenges.

    International journal of pharmaceutics: X·2026

    Enhanced anticancer efficacy of Pa-MAP 1.9 peptide-coated silver nanostars on breast cancer cells.

    Materials today. Bio·2026

    Surface-engineered milk-derived extracellular vesicles enable oral miRNA therapy against immunosuppressive pancreatic cancer.

    Materials today. Bio·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us